Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients

NCT04433988 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Institutional problems

Conditions

COVID

Interventions

DRUG: Pentoxifylline
DRUG: Placebo

Sponsor

Sadat City University